# Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

> **NCT02976753** · — · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 361 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** efmoroctocog alfa
- **DRUG:** Factor VIII

## Key facts

- **NCT ID:** NCT02976753
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2021-11-03
- **Final completion:** 2021-11-03
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976753, "Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02976753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*